Position in ESPR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,396,857
+103.7% QoQ
Ownership
0.543%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ESPR ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ESPR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 1,396,857 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | — | 685,666 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | — | 965,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | — | 945,491 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | — | 561,396 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | — | 1,921,707 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | — | 2,454,216 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | — | 2,069,117 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | — | 2,049,529 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | — | 2,085,101 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | — | 1,862,470 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | — | 1,864,332 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | — | 223,747 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | — | 186,795 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | — | 375,846 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | — | 400,836 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 880,523 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | — | 753,840 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | — | 117,303 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | — | 86,455 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | — | 75,075 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | — | 124,787 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | — | 131,330 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | — | 133,908 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | — | 142,321 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | — | 135,561 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||